Brought to you by 
Tularik (viral drugs) raises $3.9M fr. Mayfield & Genentech
13 Jul 1999
Executive Summary
Tularik (transcription factor technology) raised $3.9 million in seed funding from the Mayfield Fund, the major equity investor, and Genentech, which has a minority stake in the new company.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com